The N.N. Alexandrov National Centre beings Phase II case-control clinical trial of its immune-oncology agent called Elenagen. The Study Inoperable late-stage cancer patients with triple-negative breast cancer, ovarian cancer, stomach cancer or prostate cancer will be...